Elsevier

Neuroscience

Volume 17, Issue 1, January 1986, Pages 275-276
Neuroscience

Alzheimer plaques and cortical cholinergic innervation

https://doi.org/10.1016/0306-4522(86)90242-3Get rights and content

Reference (7)

There are more references available in the full text version of this article.

Cited by (80)

  • Cholinergic activity reflects reward expectations and predicts behavioral responses

    2023, iScience
    Citation Excerpt :

    Cholinergic neurons of the basal forebrain are important for associative learning. This idea is supported by the selective cholinergic cell loss that parallels cognitive decline in patients with Alzheimer disease.1,2 Although lesion and pharmacology studies were confirmative,3,4,5 they cannot solve how BFCNs exert their control over learning.

  • Emerging two-dimensional materials-enabled diagnosis and treatments of Alzheimer's disease: Status and future challenges

    2021, Applied Materials Today
    Citation Excerpt :

    Synapse loss is the main relevant factor for the progression of nervous system diseases and the loss of cholinergic neurons lead to memory and attention deficits [70-72]. In addition, some evidences suggest that AChE is involved in the pathogenesis of AD [73-75]. A molecular modeling study indicated that AChE interacts with Aβ peptides, and the structural motifs in AChE can promote the formation of amyloid and incorporate it into growing Aβ fibrils [71].

  • A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease

    2021, European Journal of Pharmacology
    Citation Excerpt :

    There were only few reports on the activity of α-M as biometal chelator, so it was only discussed briefly in the conclusion part. The central cholinergic system plays a key role in the regulation of cognitive function (Arendt and Bigl, 1986), control of cerebral blood flow (Biesold et al., 1989), cortical activity (Détári et al., 1999) and sleep-wake cycle (Lee et al., 2005). Acetylcholine was the first neurotransmitter to be identified, responsible for learning, memory, cognition and maintaining consciousness (Bartus et al., 1982; Perry et al., 1999).

  • Aberrant expression of the pore-forming K<inf>ATP</inf> channel subunit Kir6.2 in hippocampal reactive astrocytes in the 3xTg-AD mouse model and human Alzheimer's disease

    2016, Neuroscience
    Citation Excerpt :

    AD is a progressive neuropathological condition characterized by a decline in learning, memory and cognitive function that eventually results in dementia. Since its description more than 100 years ago, tremendous insight has been gained into the factors associated with AD including: (1) the formation of beta amyloid (Aβ) plaques and neurofibrillary tangles (Hardy et al., 1998), (2) astrogliosis (Chen et al., 2014; Osborn et al., 2016; Rodríguez et al., 2009a,b), (3) a decline in cholinergic innervation (Whitehouse et al., 1981; Arendt et al., 1983; Arendt and Bigl, 1986; German et al., 2003), (4) inflammation (Hüll et al., 1996), (5) oxidative stress (Good et al., 1996), (6) genetic predisposition (Goate et al., 1991; Tsai et al., 1994; Sherrington et al., 1995), (7) synapse and/or cell loss (Ball, 1977), and (8) regional CNS hypometabolism (Kennedy et al., 1995; Reiman et al., 1996; Mosconi et al., 2008). Despite these advances, AD is the 6th leading cause of death in America and currently there is no therapeutic strategy to prevent, cure or slow its progression.

  • Tau and tauopathies

    2016, Brain Research Bulletin
    Citation Excerpt :

    Tangles and pretangles are found in the basal nucleus even before the involvement of the entorhinal cortex in control or MCI cases (Mesulam et al., 2004; Duyckaerts et al., 2009). This subcortical pathology at early stages of the disease preceding early cortical involvement potentially indicating a subcortical origin of the pathological process has long been underestimated (Arendt et al., 1984, 2015a,b; Arendt and Bigl, 1986; Šimić et al., 2009; Elobeid et al., 2011). In addition to non-thalamic subcortical and brainstem nuclei, tau pathology can be found in the hypothalamus, thalamus, olfactory and subcortical limbic, motor and sensory systems (Arendt, 2003; for rev. see Duyckaerts et al., 2009).

View all citing articles on Scopus
View full text